IMODIUM by is a Otc medication manufactured, distributed, or labeled by Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division. Drug facts, warnings, and ingredients follow.
Ask a doctor or pharmacist before use if you are taking a prescription drug. Loperamide may interact with certain prescription drugs.
When using this product tiredness, drowsiness or dizziness may occur. Be careful when driving or operating machinery.
adults and children 12 years and over | 2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets in 24 hours |
children 9-11 years (60-95 lbs) | 1 caplet after the first loose stool; ½ caplet after each subsequent loose stool; but no more than 3 caplets in 24 hours |
children 6-8 years (48-59 lbs) | 1 caplet after the first loose stool; ½ caplet after each subsequent loose stool; but no more than 2 caplets in 24 hours |
children 2-5 years (34 to 47 lbs) | ask a doctor |
children under 2 years (up to 33 lbs) | do not use |
See New Warning and Directions
NDC: 50580-338-61
Imodium®
Loperamide HCl, 2 mg/Simethicone, 125 mg Antidiarrheal/Anti-gas
Multi-Symptom Relief
Caplet
Relieves symptoms
of diarrhea plus
24 Caplets*
*capsule-shaped tablets
Actual Size
IMODIUM
MULTI-SYMPTOM RELIEF
loperamide hydrochloride and dimethicone tablet |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division (878046358) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
IMODIUM 73017758 1005190 Live/Registered |
JANSSEN PHARMACEUTICA N.V. 1974-04-02 |